volixibat
volixibat: sourced relationships with 1 company · 2 clinical trials tracked.
volixibat evidence translation
What we can confirm
2 tracked trials
What it means
What to watch
Prepared research question
How could volixibat → MIRM affect its developer, and what evidence supports the link?
Traceable citations · Unknowns marked
See linked entities and source evidence3 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Dated Pipeline Records (1)
| Company | Dated record stage |
|---|---|
| Mirum Pharmaceuticals, Inc. (MIRM) Primary Biliary Cholangitis; Primary Sclerosing Cholangitis | Phase 3 |
Clinical Trial Registry Records (2)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in the Treatment of Cholestatic Pruritus in Patients With Primary Biliary Cholangitis
Primary endpoint: Mean change in the daily itch scores using the Adult Itch Reported Outcome (Adult ItchRO) questionnaire
A Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in the Treatment of Cholestatic Pruritus in Patients With Primary Sclerosing Cholangitis
Primary endpoint: Mean change in the daily itch scores using the Adult Itch Reported Outcome (Adult ItchRO) questionnaire
Frequently asked questions
Which companies have sourced relationships with volixibat?
volixibat has dated SEC/FDA relationship records for Mirum Pharmaceuticals, Inc..
How many clinical trials involve volixibat?
BioSniper tracks 2 clinical trials involving volixibat.